Literature DB >> 8821768

Acute liver failure and hyperammonemia increase peripheral-type benzodiazepine receptor binding and pregnenolone synthesis in mouse brain.

Y Itzhak1, A Roig-Cantisano, R S Dombro, M D Norenberg.   

Abstract

We investigated the role of brain peripheral-type benzodiazepine receptors (PBRs) and pregnenolone (a product of PBRs activation) in hepatic encephalopathy (HE)/hyperammonemia. Administration of the hepatotoxin, thioacetamide, or ammonium acetate to mice for 3 days significantly increased the number of brain PBRs (138-146% of control) and the affinity of the ligands for these receptors (2-fold). The total content of pregnenolone and its rate of synthesis in brain of the experimental animals were significantly increased. Our results suggest a novel integrated mechanism by which ammonia-induced activation of PBRs leads to elevated levels of pregnenolone-derived neurosteroids which are known to enhance GABA-ergic neurotransmission. This mechanism may play a pivotal role in pathogenesis of HE.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8821768     DOI: 10.1016/0006-8993(95)01244-3

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  23 in total

Review 1.  Does ammonia contribute to increased GABA-ergic neurotransmission in liver failure?

Authors:  E A Jones; A S Basile
Journal:  Metab Brain Dis       Date:  1998-12       Impact factor: 3.584

Review 2.  Oxidative stress in the pathogenesis of hepatic encephalopathy.

Authors:  M D Norenberg; A R Jayakumar; K V Rama Rao
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

Review 3.  Signaling factors in the mechanism of ammonia neurotoxicity.

Authors:  M D Norenberg; K V Rama Rao; A R Jayakumar
Journal:  Metab Brain Dis       Date:  2008-12-23       Impact factor: 3.584

Review 4.  Pathogenesis of hepatic encephalopathy and brain edema in acute liver failure.

Authors:  Roger F Butterworth
Journal:  J Clin Exp Hepatol       Date:  2014-07-09

5.  TGR5 signaling reduces neuroinflammation during hepatic encephalopathy.

Authors:  Matthew McMillin; Gabriel Frampton; Richard Tobin; Giuseppina Dusio; Jenny Smith; Hope Shin; Karen Newell-Rogers; Stephanie Grant; Sharon DeMorrow
Journal:  J Neurochem       Date:  2015-09-10       Impact factor: 5.372

Review 6.  Neurotoxicity of Ammonia.

Authors:  Simo S Oja; Pirjo Saransaari; Esa R Korpi
Journal:  Neurochem Res       Date:  2016-07-28       Impact factor: 3.996

Review 7.  Astroglial dysfunction in hepatic encephalopathy.

Authors:  M D Norenberg
Journal:  Metab Brain Dis       Date:  1998-12       Impact factor: 3.584

8.  In vivo imaging of cerebral "peripheral benzodiazepine binding sites" in patients with hepatic encephalopathy.

Authors:  A Cagnin; S D Taylor-Robinson; D M Forton; R B Banati
Journal:  Gut       Date:  2005-10-06       Impact factor: 23.059

Review 9.  The neurosteroid system: an emerging therapeutic target for hepatic encephalopathy.

Authors:  Samir Ahboucha; Roger F Butterworth
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

Review 10.  Glutamatergic and gabaergic neurotransmission and neuronal circuits in hepatic encephalopathy.

Authors:  Omar Cauli; Regina Rodrigo; Marta Llansola; Carmina Montoliu; Pilar Monfort; Blanca Piedrafita; Nisrin El Mlili; Jordi Boix; Ana Agustí; Vicente Felipo
Journal:  Metab Brain Dis       Date:  2008-12-16       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.